OF SPECIAL INTEREST
Obinutuzumab approved for CLL
Appointments
Clinicians receive some support to tweak stent-related antiplatelet therapy
New drugs and dosage forms
Defense Health Agency makes its debut
Informed consent remains a work in progress
News Briefs
Experience with a student-run patient medication assistance service
A new practitioner's guide to antimicrobial stewardship
Stability and compatibility of antimicrobial lock solutions
Drug absorption in celiac disease
Cost comparison of drug–drug and drug–condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine
Comparison of medication safety effectiveness among nine critical access hospitals
Medication-use evaluation with a Web application
Acknowledgment of reviewers—November 1, 2012, to October 31, 2013